| scholarly article | Q13442814 |
| P50 | author | Joseph Sodroski | Q64524473 |
| P2093 | author name string | Simon Cocklin | |
| Irwin Chaiken | |||
| Inna Lipchina | |||
| Xinzhen Yang | |||
| P2860 | cites work | The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens | Q22242262 |
| Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection | Q24538985 | ||
| Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody | Q27759364 | ||
| Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1 | Q28646812 | ||
| Antibody neutralization and escape by HIV-1 | Q29547345 | ||
| Rapid evolution of the neutralizing antibody response to HIV type 1 infection | Q29618603 | ||
| Stoichiometry of antibody neutralization of human immunodeficiency virus type 1. | Q33737656 | ||
| Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage | Q33783714 | ||
| Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1. | Q33786382 | ||
| Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo | Q33821658 | ||
| Species-specific, postentry barriers to primate immunodeficiency virus infection | Q33824990 | ||
| Envelope glycoprotein determinants of neutralization resistance in a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2) derived by passage in monkeys | Q33839485 | ||
| Antibody and virus: binding and neutralization | Q33895369 | ||
| Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus | Q34364045 | ||
| Multiple interactions across the surface of the gp120 core structure determine the global neutralization resistance phenotype of human immunodeficiency virus type 1 | Q35105006 | ||
| HIV sequence databases | Q35182711 | ||
| Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. | Q35841780 | ||
| HIV-1: the confounding variables of virus neutralization | Q36173037 | ||
| Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation. | Q36366296 | ||
| Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation | Q36685254 | ||
| Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes | Q36796806 | ||
| Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1 | Q39595900 | ||
| Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1. | Q39610187 | ||
| Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies | Q39698363 | ||
| Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site | Q39699375 | ||
| Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. | Q39868309 | ||
| Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex | Q39878965 | ||
| Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity | Q40546009 | ||
| Passage of HIV-1 molecular clones into different cell lines confers differential sensitivity to neutralization | Q41076585 | ||
| The ratio of defective HIV-1 particles to replication-competent infectious virions | Q41492441 | ||
| Neutralizing Antibody Response During Human Immunodeficiency Virus Type 1 Infection: Type and Group Specificity and Viral Escape | Q41558189 | ||
| Factors underlying spontaneous inactivation and susceptibility to neutralization of human immunodeficiency virus | Q41611077 | ||
| Dissociation of gp120 from HIV-1 virions induced by soluble CD4. | Q41714439 | ||
| An unrelated monoclonal antibody neutralizes human immunodeficiency virus type 1 by binding to an artificial epitope engineered in a functionally neutral region of the viral envelope glycoproteins | Q42086489 | ||
| Morphometric analysis of envelope glycoprotein gp120 distribution on HIV-1 virions | Q44285196 | ||
| Neutralization escape in human immunodeficiency virus type 1-infected long-term nonprogressors | Q45750292 | ||
| Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus | Q45848179 | ||
| Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera. | Q45849314 | ||
| Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus | Q45859822 | ||
| Distinct biological and serological properties of human immunodeficiency viruses from the brain. | Q46038323 | ||
| Native HIV type 1 virion surface structures: relationships between antibody binding and neutralization or lessons from the viral capture assay | Q47444177 | ||
| Retrieval and on-the-fly alignment of sequence fragments from the HIV database | Q48679004 | ||
| Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. | Q55487007 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 11404-11408 | |
| P577 | publication date | 2006-09-06 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralization | |
| P478 | volume | 80 |
| Q26829865 | A Blueprint for HIV Vaccine Discovery |
| Q27489392 | Antibodies against viruses: passive and active immunization |
| Q90677040 | Antibody responses to the HIV-1 envelope high mannose patch |
| Q36172128 | Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding |
| Q59354834 | Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies |
| Q40679052 | Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design |
| Q52721542 | Comparison of Uncleaved and Mature Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimers. |
| Q39177719 | Critical amino acids within the human immunodeficiency virus type 1 envelope glycoprotein V4 N- and C-terminals contribute to virus entry |
| Q39454698 | Env-glycoprotein heterogeneity as a source of apparent synergy and enhanced cooperativity in inhibition of HIV-1 infection by neutralizing antibodies and entry inhibitors |
| Q37051613 | Estimating the stoichiometry of human immunodeficiency virus entry |
| Q48133582 | Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes |
| Q37958563 | HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem |
| Q38897259 | HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies |
| Q37055800 | HIV-host interactome revealed directly from infected cells |
| Q39843176 | Introduction of exogenous epitopes in the variable regions of the human immunodeficiency virus type 1 envelope glycoprotein: effect on viral infectivity and the neutralization phenotype |
| Q34157802 | Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine |
| Q36083337 | Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials |
| Q41967451 | Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody |
| Q37419199 | Modeling virus- and antibody-specific factors to predict human immunodeficiency virus neutralization efficiency. |
| Q36404752 | Monoclonal antibody m18 paratope leading to dual receptor antagonism of HIV-1 gp120. |
| Q39704592 | Neutralization efficiency is greatly enhanced by bivalent binding of an antibody to epitopes in the V4 region and the membrane-proximal external region within one trimer of human immunodeficiency virus type 1 glycoproteins |
| Q35208657 | Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination |
| Q30358769 | Production and characterization of high-affinity human monoclonal antibodies to human immunodeficiency virus type 1 envelope glycoproteins in a mouse model expressing human immunoglobulins. |
| Q36559735 | Proteolytic processing of the human immunodeficiency virus envelope glycoprotein precursor decreases conformational flexibility |
| Q36837815 | Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralization |
| Q34064787 | Structural determinants for affinity enhancement of a dual antagonist peptide entry inhibitor of human immunodeficiency virus type-1. |
| Q27678306 | Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 |
| Q41287677 | The V4 and V5 Variable Loops of HIV-1 Envelope Glycoprotein Are Tolerant to Insertion of Green Fluorescent Protein and Are Useful Targets for Labeling |
| Q36607016 | The highly conserved layer-3 component of the HIV-1 gp120 inner domain is critical for CD4-required conformational transitions. |
| Q37099851 | The human immunodeficiency virus type 1 envelope spike of primary viruses can suppress antibody access to variable regions |
Search more.